New for ASM Microbe 2020!

Submit your Emerging Science to ASM Microbe!  Submissions in this category should highlight novel, unanticipated, high impact or disruptive studies with a time-sensitive urgency to present at Microbe.  Such findings should have clear public impact and/or advance a field significantly, or into new directions.

An example in this category would be work related to a new outbreak,  like the novel coronavirus identified in late 2019 and early 2020.  Another example would be research describing a newly uncovered biological mechanism. If accepted, these emerging science abstracts would be offered an oral presentation in a Lounge and Learn slide session at the meeting. They will not present a poster in the Exhibit and Poster Hall.  

Emerging Science Slide Sessions

Emerging Science Slide Sessions will be placed in the Lounge and Learns located throughout theconvention center. Each presenter will have up to five minutes to present a three-slide PowerPoint slides on his or her research and take questions from the audience. The entire session lasts up to 45 minutes, with up to 8 speakers presenting five minute presentations. They will occur on the Friday, Saturday and Sunday of the meeting.
 
Emergent findings with potentially high impact definition:   Submissions in this category should highlight novel, unanticipated, high impact or disruptive studies with a time-sensitive urgency to present at Microbe.  Such findings should have clear public impact and/or advance a field significantly, or into new directions. An example in this category would be work related to a new outbreak,  like the novel coronavirus identified in late 2019 and early 2020.  Another example would be research describing a newly uncovered biological mechanism.   
 
This is not an opportunity to submit an abstract that only describes a rigorous study that could have been submitted during the general submission period.  In fact, a high number of the general submission abstracts would be rejected if submitted in the emergent findings category.  

What You Need Before Submitting Your Abstract

(Already on the Abstracts’ page of the web site and still applicable)
  1. Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Note: the title is not included in the total character count of 2200).
  2. Abstract Body Text: Your abstract may have up to 2200 characters, which does not include title, authors, groups, and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes, or file upload.
  3. Author(s) Information: Author(s)'s name(s), institution(s), location(s), title(s). 
  4. CE Disclosures: Relative to this activity, instructors, planners, content reviewers and managers who affect the content of a CME/CE activity are required to disclose relevant financial relationships they have with commercial interests (i.e., any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients).

Abstract Guidelines

All Submitted Abstracts
  • It is preferred that ASM Microbe 2020 be the first major presentation of the abstract. 
  • A presenter may be a presenter on more than one abstract.
  • Programming decisions are considered final. 
  • Abstracts must be well written and easy to understand.
  • Approval of all co-authors must be obtained before placing their names on an abstract.
  • Submission of multiple overlapping abstracts is discouraged.
Clinical/Educational Tracks (AAR, CPHM, CIV, POM)
  • The reason for the study or how the study came about (e.g. hypothesis, discovery or central question) should be clearly stated.
  • Methods must be included.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation. Please note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
  • Scientific presentations at ASM Microbe 2020 will be expected to transparently report a study’s scientific rigor, including, but not limited to the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis; and 5) interpretation and report of results. Other key components of scientific rigor included, if applicable, are sample size, randomization, blinding, and replication.
Basic Science Tracks (AES, EEB, HMB, MBP)
  • The reason for the study or how the study came about (e.g. hypothesis, discovery or central question) should be clearly stated.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • Conclusion(s) should be made, but the study does not need to be fully complete (the standard to present at ASM Microbe is not the same as to publish in a journal). 
  • Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track. 
Scientific presentations at ASM Microbe 2020 will be expected to transparently report a study's scientific rigor, including, but not limited to the following: 1) experimental design; 2) interpretation and report of results.